Your session is about to expire
← Back to Search
MIACH Scaffold for ACL Tear (BEAR Trial)
BEAR Trial Summary
This trial will test a new device for repairing a torn ACL. 10 patients will use the new device, and 10 will have standard ACL surgery.
BEAR Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BEAR Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: ACL repair with MIACH scaffold
- Group 2: Standard ACL reconstruction
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this clinical trial encompass seniors as participants?
"The age range for those eligible to join this trial is from 18 years old up until 35."
Has the MIACH Scaffold for ACL Repair been approved by the FDA?
"The potential safety of ACL Repair with MIACH Scaffold was rated a 1, as this is an early-stage trial that has generated limited data on both effectiveness and safety."
Is it possible for me to enroll in this investigation?
"This medical trial aims to enrol 20 individuals, aged 18-35 years old and suffering from a recent ACL injury (aside from 90 days of onset)."
Does the research team continue to accept participants for this investigation?
"The evidence found on clinicaltrials.gov reveals that this trial is not currently seeking patient volunteers; the first posting of this study was in January 2015, with its last update being March 2021. However, there are 100 other medical trials actively enrolling patients at present."
Share this study with friends
Copy Link
Messenger